Policy

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

An expert outlines some common experiences of physicians facing infertility and shares steps to optimize psychological health and support colleagues.

PBMs are powerful middlemen that control prescription drug access for millions of Americans, and their business model is nefarious -- but currently legal.

Monthly report shows gains for hospitals, home health care services.

As a result of shifts in the primary care landscape, Bain & Company has made important adjustments to their 2030 market share forecast from two years ago.

How is life different across the pond? UK babies can expect to live longer than newborn Americans.

Community-based primary care has been hollowed out over the past 25 years, starting with the advent of electronic health records.

RAND study found hospitals have increased how frequently they say patients need the highest level of care

The rate of pharmacy store closures has more than doubled in recent years in what researchers call an “unprecedented decline.”

The Commonwealth Fund compares United States with other developed nations.

Independent oncologists are important for patient health and cost-effective care

Pradeep Kumar Jain, senior director of health care at Tredence, outlined five significant predictions for 2025.

Employers face tough decisions on health care coverage as costs continue to rise.

Lawmaker discusses state of the nation’s physician workforce – and the rise of part-time practice.

The clock is ticking for lawmakers to approve policies that could affect U.S. health care.

Jay w. Lee, MD. MPH, FAAFP, board member at the AAFP and medical director at Integrated Health Partners of Southern California, discuss how to overcome vaccine hesitancy in patients.

There’s a tasty stock market stew simmering into 2025.

O’Neill tapped to serve as deputy secretary, Bhattacharya to lead National Institutes of Health.

Proposals would require more public data on prior authorization processes and whether those advance health equity.

Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.

With the majority of devices manufactured outside the U.S., any increase in tariffs is likely to drive up health care costs

On behalf of Patients for Safer Nuclear Medicine, we object to the content of Cathy Sue Cutler’s column dismissing efforts to improve nuclear medicine safety and transparency.

President-elect Donald Trump's nominations for major positions of leadership in health care in his new administration—including HHS, CMS, CDC, FDA, NIH and surgeon general.

Dave Weldon, MD, Marty Makary, MD, MPH, FACS, and Janette Nesheiwat, MD, are the President-elect’s picks for CDC director, FDA commissioner and surgeon general.